Inactive Instrument

News Pharmacolog i Uppsala AB (publ) Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm Other stock markets
-	-

Apr. 24	Perpetua Medical AB Appoints Camilla Lonn as CFO	CI
Apr. 23	Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) appoints Camilla Lönn as CFO	Apr. 24	AQ
Perpetua Medical AB Appoints Camilla Lonn as CFO	Apr. 24	CI
Perpetua Medical AB (formerly Pharmacolog i Uppsala AB) announces its first day of trading on Nasdaq First North under its new company name	Apr. 23	AQ
Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	Apr. 23	CI
Pharmacolog i Uppsala AB will Change its Name to Perpetua Medical AB	Apr. 23	CI
ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024	Apr. 16	AQ
Pharmacolog publishes annual report for 2023	Apr. 16	AQ
Nolsterby Invest AB has increased its holding in Pharmacolog	Apr. 08	AQ
Pharmacolog announces the appointment of Anders Hedlund as interim CEO	Apr. 04	AQ
Pharmacolog i Uppsala AB Announces the Appointment of Anders Hedlund as Interim CEO, Effective from May 1, 2024	Apr. 04	CI
NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)	Mar. 14	AQ
Pharmacolog provides update on new business direction and proposes name change	Mar. 14	AQ
Pharmacolog announces upcoming change in management	Mar. 01	AQ
Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024	Mar. 01	CI
Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million	Feb. 27	AQ
Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million	Feb. 20	AQ
The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024	Feb. 20	AQ
Year-end bulletin Pharmacolog 2023	Feb. 16	AQ
Pharmacolog i Uppsala AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmacolog i Uppsala AB (publ) Nasdaq Stockholm

Equities

Summary

Filters